Aveanna Healthcare Holdings (AVAH) Cash & Equivalents (2021 - 2026)

Aveanna Healthcare Holdings (AVAH) has reported Cash & Equivalents for 6 consecutive years, with $193.3 million the latest figure, recorded in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $193.3 million, up 129.29% year-over-year; the trailing twelve-month figure through Jan 2026 was $193.3 million (up 129.29% YoY), and the FY2026 annual result was $193.3 million, up 129.29% from the prior year.
• Cash & Equivalents was $193.3 million for Q1 2026 at Aveanna Healthcare Holdings, up from $145.9 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $193.3 million in Q1 2026 and troughed at $17.4 million in Q2 2022.
• Average Cash & Equivalents over 5 years is $62.8 million, with a median of $47.7 million recorded in 2024.
• Year-over-year, Cash & Equivalents sank 83.61% in 2022 and soared 129.29% in 2026.
• Over 5 years, Cash & Equivalents stood at $19.2 million in 2022, then soared by 128.66% to $43.9 million in 2023, then soared by 91.82% to $84.3 million in 2024, then jumped by 73.06% to $145.9 million in 2025, then soared by 32.49% to $193.3 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $193.3 million in Q1 2026, $145.9 million in Q3 2025, and $100.7 million in Q2 2025.